Skip to main content
Journal of High School Science
  • Menu
  • Articles
    • Case study
    • Original article
    • Review paper
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Metrics
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:40249/feed
Original article
Vol. 4, Issue 3, 2020August 30, 2020 CDT

Apparent deficiencies in the phase III data for Seres Therapeutics, SER-109: a closer inspection of the data prior to a decision by the FDA expert committee.

Mikaela Bullari, Jonathan Darauay, Khadijah Edhi, Karen Elizondo, Leen Elyas, Hermela Gebregzabher, Vanessa Griffin, Zahra Khan, Daniela Lopez, Grace Nguyen, Job Oganda, Sana Omar, Shireesh Apte,
seres-109microbiomeclostridium difficile infectionclinical trialgendersecondary bile acidsdysbioticfecal microbiome transplantationrecurrentantibiotic
https://doi.org/10.64336/001c.16766
Journal of High School Science
Bullari, Mikaela, Jonathan Darauay, Khadijah Edhi, Karen Elizondo, Leen Elyas, Hermela Gebregzabher, Vanessa Griffin, et al. 2020. “Apparent Deficiencies in the Phase III Data for Seres Therapeutics, SER-109: A Closer Inspection of the Data Prior to a Decision by the FDA Expert Committee.” Journal of High School Science 4 (3). https:/​/​doi.org/​10.64336/​001c.16766.
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system